<?xml version="1.0" encoding="UTF-8"?>
<p id="para230">Some direct evidence was available for COVID-19 (64 studies, of which seven were comparative in design),
 <xref rid="bib36" ref-type="bibr">36</xref>, 
 <xref rid="bib37" ref-type="bibr">37</xref>, 
 <xref rid="bib40" ref-type="bibr">40</xref>, 
 <xref rid="bib41" ref-type="bibr">41</xref>, 
 <xref rid="bib44" ref-type="bibr">44</xref>, 
 <xref rid="bib52" ref-type="bibr">52</xref>, 
 <xref rid="bib70" ref-type="bibr">70</xref> but most studies reported on SARS (n=55) or MERS (n=25; 
 <xref rid="sec1" ref-type="sec">appendix pp 6–12</xref>). Of the 44 comparative studies, 40 included WHO-defined confirmed cases, one included both confirmed and probable cases, and the remaining three studies included probable cases. There was no effect-modification by case-definition (distance p
 <sub>interaction</sub>=0·41; mask p
 <sub>interaction</sub>=0·46; all cases for eye protection were confirmed). Most studies reported on bundled interventions, including different components of PPE and distancing, which was usually addressed by statistical adjustment. The included studies all occurred during recurrent or novel outbreak settings of COVID-19, SARS, or MERS.
</p>
